CWG
INFI

C WorldWide Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

C WorldWide Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,680
Closed -$54K – 128
2016
Q2 		$54K Hold
40,680
– – ﹤0.01% 117
2016
Q1 		$214K Hold
40,680
– – ﹤0.01% 120
2015
Q4 		$319K Hold
40,680
– – 0.01% 129
2015
Q3 		$344K Buy
+40,680
New +$375K 0.01% 128

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

C WorldWide Group's INFI Position: Q3 2016 in Review

C WorldWide Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2016, closing a stake of 40,680 shares — an estimated $54K sold.

C WorldWide Group first reported a position in INFI in Q3 2015 and held it in 4 quarters. The position peaked at $344K in Q3 2015. 99 funds tracked by Wall St. Rank hold INFI as of Q3 2016.

  • C WorldWide Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • C WorldWide Group sold 40,680 Infinity Pharmaceuticals, Inc. shares in Q3 2016, an estimated $54K.
  • C WorldWide Group first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2015 and held it in 4 quarters.
  • C WorldWide Group's Infinity Pharmaceuticals, Inc. position peaked at $344K in Q3 2015.
  • 99 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2016.

Based on C WorldWide Group's 13F filing for Q3 2016, filed 3 Nov 2016.